Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis

Summary

Rheumatoid arthritis were randomized to a 6-month treatment of oral dextromethorphan hydrobromide or placebo as an add-on therapy to traditional disease-modifying anti-rheumatic drugs (DMARDs). Disease activity were assessed.

Timeline

Start

2010-01

Primary completion

2012-09

Completion

2012-09

Drugs

Indications